XCath secures FDA breakthrough designation for remote thrombectomy robot
With the FDA designate in hand, XCath will further the development of its system that is intended to broaden access to stroke treatment globally.
Explore our marketing solutions
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
